Volume : 4
Issue : 4
Online ISSN : 2394-2754
Print ISSN : 2394-2746
Article First Page : 369
Article End Page : 372
Eclampsia accounts for 50,000 maternal deaths a year worldwide. The maternal case fatality rate is 1.8% and 35% of eclamptics will have one major complication.
Objective: objective of study was to improve maternal and fetal outcome with single dose of magnesium sulphate therapy.
Materials and Method: The present prospective study was undertaken among women aged between 18-35 years outpatient’s Department of gynecology in Karnataka Institute of Medical Sciences (KIMS) Hubli. Permission for the study was obtained from the College authorities prior to commencement. The study was undertaken during December 2009 to November 2010.
Results: 100 cases of eclampsia admitted to Karnataka Institute of Health Sciences, Hubli were belong to lower socio economic status, majority of them were Hindus and illiterates. 82% had vaginal delivery and 15% had LSCS for fetal indication. In 52 cases, induction was done. LSCS was done in 11 cases in induction group, 8 cases were for fetal distress and 3 were for failed induction. Maternal mortality in our study was 1% and the cause was acute pulmonary edema. Commonest complication encountered in our study was the renal failure. In our study 70 of the them were live born out of which 49 were pre term and 21 were term. 71% of the them had birth weight of more than 1.5Kg. Among this 46 perinatal deaths, 30 were still born and 16 were neonatal death, thus giving the perinatal mortality of 46%.
Conclusion: It was concluded that Magnesium sulphate is safe and effective in controlling convulsions with improved maternal and perinatal outcome.
Keywords: Perinatal mortality, Maternal death, Magnesium sulphate regime, Eclapmsia, convulsion